Top Markets
Coin of the day
Guangzhou Wondfo Biotech Co.,Ltd Guangzhou Wondfo Biotech Co.,Ltd

Guangzhou Wondfo Biotech Co.,Ltd

300482
Rangering i aksjer #9000
Guangzhou Wondfo Biotech Co.,Ltd operates as a biotechnology enterprise,... Guangzhou Wondfo Biotech Co.,Ltd operates as a biotechnology enterprise, specializing in the research, development, production, and distribution of point-of-care testing (POCT) products. The company additionally provides rapid diagnostic tools and comprehensive solutions for managing chronic diseases. Its product catalog features an array of rapid test kits, addressing conditions like COVID-19, substance abuse, certain cancers, infectious diseases, fertility, and sexually transmitted infections. Furthermore, Wondfo Biotech offers immunofluorescence devices designed to identify cardiovascular conditions, inflammatory markers, kidney damage, hormonal imbalances (including sex hormones and thyroid function), diabetes, and specific tumor indicators. The firm also supplies analytical instruments, such as blood gas, optical coagulation, and dry chemistry analyzers. Established in 1992, the company's main operations are based in Guangzhou, China.
Aksjekurs
$2.39
Sist synkronisert: 2026-08-28
Markedsverdi
$1.12B
Endring (1 dag)
0.24%
Endring (1 år)
-23.68%
Land
CN
Handel Guangzhou Wondfo Biotech Co.,Ltd (300482)

Kategori

Inntekter for Guangzhou Wondfo Biotech Co.,Ltd (300482)
Inntekter i 2026 TTM: 0
Ifølge Guangzhou Wondfo Biotech Co.,Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Guangzhou Wondfo Biotech Co.,Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US